The efficacy and safety of omalizumab in refractory chronic spontaneous urticaria: real-life experience in Turkey

Bulur, Isil; BÜLBÜL BAŞKAN, EMEL; Ozdemir, Mustafa; Balevi, Ali; Goncu, Emek; Altunay, Ilknur; Gonul, Muzeyyen; Ergin, Can; ERTAM SAĞDUYU, İLGEN; ERDOĞAN, HİLAL; BİLGİN, MUZAFFER; Erdem, Mustafa

doi:10.15570/actaapa.2018.25

The efficacy and safety of omalizumab in refractory chronic spontaneous urticaria: real-life experience in Turkey

Copy For Citation

Bulur I., BÜLBÜL BAŞKAN E., Ozdemir M., Balevi A., Goncu E. K., Altunay I., ...More

ACTA DERMATOVENEROLOGICA ALPINA PANNONICA ET ADRIATICA, vol.27, no.3, pp.121-126, 2018 (ESCI)

Publication Type: Article / Article
Volume: 27 Issue: 3
Publication Date: 2018
Doi Number: 10.15570/actaapa.2018.25
Journal Name: ACTA DERMATOVENEROLOGICA ALPINA PANNONICA ET ADRIATICA
Journal Indexes: Emerging Sources Citation Index (ESCI), Scopus
Page Numbers: pp.121-126
Bursa Uludag University Affiliated: Yes

Abstract

Introduction: This study used real-world data to evaluate the effectiveness and reliability of omalizumab in treating recalcitrant chronic spontaneous urticaria in Turkish patients.